journal
MENU ▼
Read by QxMD icon Read
search

Surgical Clinics of North America

journal
https://www.readbyqxmd.com/read/29502783/current-concepts-and-treatments-for-venous-disease
#1
EDITORIAL
Marc A Passman
No abstract text is available yet for this article.
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502782/foreword
#2
EDITORIAL
Ronald F Martin
No abstract text is available yet for this article.
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502781/liquid-and-foam-sclerotherapy-for-spider-and-varicose-veins
#3
REVIEW
Kathleen Gibson, Krissa Gunderson
Sclerotherapy has wide applicability in treating venous disease at every stage of clinical disease. The various sclerosant drugs and formulations each have unique properties, utilities, and side effects. Treating physicians should be aware of the differences between agents, accounting for disease presentation, vein characteristics, and patient comorbidities when selecting the appropriate sclerosing agents. Successful outcomes rely on proper patient evaluation and assessment for contraindications to sclerotherapy...
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502780/phlebectomy-techniques-for-varicose-veins
#4
REVIEW
Daniel F Geersen, Cynthia E K Shortell
Ambulatory phlebectomy is a well-known and widely used procedure for residual symptomatic venous disease. Tumescent anesthesia complements the procedure, providing the ability to perform this intervention in a wide range of practice settings. The procedures are well tolerated by most patients, and complications are rare. They include venous thromboembolism, infection, and hematoma and are generally simple to manage. Alternative and emerging techniques of powered phlebectomy and cyanoacrylate glue are providing alternative forms for treatment and will advance the practice further...
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502779/thermal-and-nonthermal-endovenous-ablation-options-for-treatment-of-superficial-venous-insufficiency
#5
REVIEW
Misaki M Kiguchi, Ellen D Dillavou
Open saphenous removal, phlebectomy, and venous ligation were historic mainstays of surgical treatment of venous disease. Duplex ultrasound has become standard to diagnose venous insufficiency. Percutaneous modalities have allowed treatments to include thermal and nonthermal endovenous ablation. These treatments vary in preoperative planning, procedural steps, and postprocedural care, but all are safe and effective. An individualized approach should be taken in determining which modality is offered to each patient...
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502778/open-surgical-reconstruction-for-deep-venous-occlusion-and-valvular-incompetence
#6
REVIEW
Katherin E Leckie, Michael C Dalsing
This article considers the potential options for open deep venous reconstructions based on pathologic complication (obstruction vs insufficiency), anatomic location, presence of disease-free venous architecture, and patient need. Other things being equal, less invasive techniques and disease locations will be attempted as first-line therapy. When other options fail and symptoms persist, open venous surgery by means of bypass for obstructive disease and valve repair or replacement for deep venous insufficiency remains a viable option...
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502777/role-of-venous-stenting-for-iliofemoral-and-vena-cava-venous-obstruction
#7
REVIEW
Adham N Abou Ali, Efthymios D Avgerinos, Rabih A Chaer
Venous stenting for CVD is being increasingly used as more evidence accumulates supporting the open vein hypothesis and supporting the safety, efficacy, and durability of these interventions. As such, they can be offered to patients with advanced age and complex comorbidities. Future studies should focus on reporting outcomes specific to the underlying venous pathologic condition (thrombotic vs nonthrombotic and acute vs chronic) to provide better evidence for stenting in CVD, and the outcomes of new stent design with dedicated venous indications...
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502776/optimal-compression-therapy-and-wound-care-for-venous-ulcers
#8
REVIEW
Fedor Lurie, Samir Bittar, Gregory Kasper
Venous leg ulcers remain a major public health issue with significant economic impact. Two main components of the management of patients with venous leg ulcers are compression therapy and wound care. This article addresses principles and specific aspects of compression therapy and focal wound care for patients with venous leg ulcers.
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502775/pathophysiology-of-chronic-venous-disease-and-venous-ulcers
#9
REVIEW
Joseph D Raffetto
Chronic venous disease and venous leg ulceration are a common disease affecting millions of individuals. The fundamental problem is venous hypertension with resultant clinical manifestations of venous disease including varicose veins, skin changes, and venous leg ulceration. The pathophysiology leading to venous hypertension is complex and multifactorial, involving genetic predisposition, environmental factors, hormones, endothelial dysfunction, inflammatory cells and molecules and activation on the endothelium and vein wall, and disturbances in the balance of cytokines and matrix metalloproteinases...
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502774/endovenous-and-operative-treatment-of-superior-vena-cava-syndrome
#10
REVIEW
Manju Kalra, Indrani Sen, Peter Gloviczki
Few areas of venous disease provide a more satisfying experience for both the patient and the vascular specialist than reconstruction for superior vena cava (SVC) syndrome. Relief from severe, frequently incapacitating symptoms of venous congestion of the head and neck is almost instantaneous, and benefit after reconstruction is generally long lasting. This article reviews the etiologic factors, clinical presentation, and diagnostic evaluation of SVC syndrome, and current techniques and results for the endovascular and open surgical treatment of SVC occlusion...
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502773/inferior-vena-cava-filters-current-indications-techniques-and-recommendations
#11
REVIEW
Cindy P Ha, John E Rectenwald
The vena cava filter (VCF) is intended to prevent the progression of deep venous thrombosis to pulmonary embolism. Recently, the indications for VCF placement have expanded, likely due in part to newer retrievable inferior vena caval filters and minimally invasive techniques. This article reviews the available VCFs, the indications for use, the techniques for placement, and possible outcomes and complications.
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502772/pulmonary-embolism-current-role-of-catheter-treatment-options-and-operative-thrombectomy
#12
REVIEW
Michael Jolly, John Phillips
Pulmonary embolism remains a leading cause of death in the United States, with an estimated 180,000 deaths per year. Guideline-based treatment in most cases recommends oral anticoagulation for 3 months. However, in a small subset of patients, the "submassive, high-risk" by current nomenclature, with hemodynamic instability, more advanced therapeutic options are available. Treatment modalities to extract the thromboembolism and reduce pressure overload in the cardiopulmonary system include use of intravenous or catheter-directed thrombolytic agents, catheter-directed mechanical thrombectomy, and surgical embolectomy...
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502771/advances-in-operative-thrombectomy-for-lower-extremity-venous-thrombosis
#13
REVIEW
Matthew C Koopmann, Robert B McLafferty
Lower extremity deep venous thrombosis is a leading cause of morbidity and mortality. The mainstay of therapy is medical. However, anticoagulation does not remove the thrombus and restore venous patency. In select patients, early thrombus removal and anticoagulation can restore venous patency, preserve venous valve function, and may reduce the incidence of postthrombotic syndrome. Catheter-directed therapies are minimally invasive with low complication rates. However, in patients with a contraindication to thrombolytic agents who can receive anticoagulation, open thrombectomy should be considered if indications for thrombus removal are met and patients are good operative risks...
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502770/catheter-directed-therapy-options-for-iliofemoral-venous-thrombosis
#14
REVIEW
Deepak Sudheendra, Suresh Vedantham
Proximal deep venous thrombosis (DVT) is linked to a 50% risk of pulmonary embolism and a 50% risk of postthrombotic syndrome. This article reviews catheter-directed thrombolysis options for iliofemoral DVT and discusses the risks, benefits, and techniques commonly used in performing endovascular procedures for iliofemoral DVT.
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502769/evidence-based-therapies-for-pharmacologic-prevention-and-treatment-of-acute-deep-vein-thrombosis-and-pulmonary-embolism
#15
REVIEW
Ben Jacobs, Peter K Henke
Venous thromboembolism (VTE) remains a significant mortal and morbid disease. The major risks have not changed and many patients present with unprovoked VTE disease. Prevention of VTE in hospitalized patients depends on comprehensive risk factor assessment, with an individual risk score. Proper and timely prophylaxis with mechanical, pharmacologic, or both is then effective. Treatment of VTE with parenteral anticoagulation followed by either a direct oral anticoagulant or warfarin is standard to reduce risk of VTE recurrence and death...
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502768/new-trends-in-anticoagulation-therapy
#16
REVIEW
Margaret Smith, Glenn Wakam, Thomas Wakefield, Andrea Obi
Anticoagulation pharmacy has been dramatically altered with US Food and Drug Administration (FDA) approval of 5 direct oral anticoagulants, 1 novel reversal agent and, a second designated for fast-track approval. Trial data surrounding current trends in anticoagulant choice for VTE, reversal, and bridging are constantly redefining practice. Extended therapy for unprovoked VTE has expanded to include low-dose direct oral anticoagulants, aspirin, and the use of the HERDOO2 system to identify women who can stop anticoagulant therapy without increased risk of recurrent VTE...
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29502767/duplex-ultrasound-for-the-diagnosis-of-acute-and-chronic-venous-diseases
#17
REVIEW
Raudel Garcia, Nicos Labropoulos
Venous diseases are highly prevalent, mostly caused by valve incompetence and/or obstruction of the vein lumen. Signs and symptoms are diverse and unspecific. Careful clinical assessment and imaging interpretation are crucial to diagnosis. Duplex ultrasound is the first choice and often the gold standard imaging technique for this purpose, providing information on the anatomy and function of the veins. This article describes the sonographic anatomic and hemodynamic criteria used for the diagnosis of venous reflux, venous obstruction, and the most frequent complications after interventions in the superficial, perforating, and deep venous systems...
April 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29191283/a-symposium-on-pancreatic-cancer-time-for-a-paradigm-shift-an-overview-and-personal-reflections
#18
EDITORIAL
Avram M Cooperman
No abstract text is available yet for this article.
February 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29191282/foreword
#19
EDITORIAL
Ronald F Martin
No abstract text is available yet for this article.
February 2018: Surgical Clinics of North America
https://www.readbyqxmd.com/read/29191281/adjuvant-or-neoadjuvant-therapy-in-the-treatment-in-pancreatic-malignancies-where-are-we
#20
REVIEW
Robert A Wolff
Since the advent of modern surgery for pancreatic cancer, clinicians have recognized this cancer's propensity to recur locally, metastasize, and cause death. Despite significant efforts to improve patient outcomes with better adjuvant therapy, only modest gains in survival have been observed. An alternative strategy of neoadjuvant therapy followed by surgery has the potential to improve patient selection and survival, and expand the pool of patients eligible for curative surgery. This article summarizes large, randomized trials of adjuvant therapy, explains the limitations imposed by up-front surgery, and suggests neoadjuvant therapy as a rational alternative to initial surgery and adjuvant therapy...
February 2018: Surgical Clinics of North America
journal
journal
21568
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"